Versant Capital Management’s CRISPR Therapeutics CRSP Stock Holding History

Versant Capital Management’s Portfolio CRSP Stock Details CRSP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	$972	Hold
2025 Q2	$730	Buy
2025 Q1	–	Sell
2024 Q4	$1.38K	Hold
2024 Q3	$1.64K	Buy
2023 Q3	–	Sell
2023 Q2	$2.36K	Buy